These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11854194)

  • 21. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J; Chen X; Li B; Gu T; Meng X; Kong W; Wu Y
    Immunol Res; 2018 Aug; 66(4):528-536. PubMed ID: 30128745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PrtA immunization fails to protect against pulmonary and invasive infection by Streptococcus pneumoniae.
    Hsu CF; Hsiao CH; Tseng SF; Chen JR; Liao YJ; Chen SJ; Lin CS; Sytwu HK; Chuang YP
    Respir Res; 2018 Sep; 19(1):187. PubMed ID: 30253765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
    Yamamoto M; McDaniel LS; Kawabata K; Briles DE; Jackson RJ; McGhee JR; Kiyono H
    Infect Immun; 1997 Feb; 65(2):640-4. PubMed ID: 9009325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against pneumococcal infection elicited by immunization with multiple pneumococcal heat shock proteins.
    Cao J; Zhang X; Gong Y; Zhang Y; Cui Y; Lai X; Yin Y; Li M; Li D; Zhang L
    Vaccine; 2013 Aug; 31(35):3564-71. PubMed ID: 23727004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
    Tostes RO; Rodrigues TC; da Silva JB; Schanoski AS; Oliveira ML; Miyaji EN
    PLoS One; 2017; 12(1):e0170157. PubMed ID: 28103277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study.
    Carmona Martinez A; Prymula R; Miranda Valdivieso M; Otero Reigada MDC; Merino Arribas JM; Brzostek J; Szenborn L; Ruzkova R; Horn MR; Jackowska T; Centeno-Malfaz F; Traskine M; Dobbelaere K; Borys D
    Vaccine; 2019 Jan; 37(1):176-186. PubMed ID: 30054160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization.
    VanCott JL; Kobayashi T; Yamamoto M; Pillai S; McGhee JR; Kiyono H
    Vaccine; 1996 Apr; 14(5):392-8. PubMed ID: 8735550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.
    Brown JS; Ogunniyi AD; Woodrow MC; Holden DW; Paton JC
    Infect Immun; 2001 Nov; 69(11):6702-6. PubMed ID: 11598041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of recombinant acylated pneumococcal surface adhesin A of Streptococcus pneumoniae by mass spectrometry.
    De BK; Woolfitt AR; Barr JR; Daneshvar MI; Sampson JS; Ades EW; Carlone GM
    Arch Biochem Biophys; 2003 Nov; 419(2):147-57. PubMed ID: 14592458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
    Villena J; Medina M; Raya R; Alvarez S
    Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
    Oliveira ML; Arêas AP; Campos IB; Monedero V; Perez-Martínez G; Miyaji EN; Leite LC; Aires KA; Lee Ho P
    Microbes Infect; 2006 Apr; 8(4):1016-24. PubMed ID: 16549380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
    Shah P; Briles DE; King J; Hale Y; Swiatlo E
    Exp Biol Med (Maywood); 2009 Apr; 234(4):403-9. PubMed ID: 19176871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in mucosal immunization for protection against pneumococcal pneumonia.
    Gonçalves VM; Kaneko K; Solórzano C; MacLoughlin R; Saleem I; Miyaji EN
    Expert Rev Vaccines; 2019 Aug; 18(8):781-792. PubMed ID: 31305196
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
    Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins.
    Hamel J; Charland N; Pineau I; Ouellet C; Rioux S; Martin D; Brodeur BR
    Infect Immun; 2004 May; 72(5):2659-70. PubMed ID: 15102774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.
    Briles DE; Hollingshead SK; Paton JC; Ades EW; Novak L; van Ginkel FW; Benjamin WH
    J Infect Dis; 2003 Aug; 188(3):339-48. PubMed ID: 12870114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained functional serotype-specific antibody after primary and secondary vaccinations with a pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.
    Ohshima N; Nagai H; Matsui H; Akashi S; Makino T; Akeda Y; Oishi K
    Vaccine; 2014 Feb; 32(10):1181-6. PubMed ID: 24120483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.